Clinical Trial Update: Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and tolerability of ziprasidone in children and adolescents with Bipolar I Disorder (manic or mixed) completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-04-03